Genomma Lab Internacional S.A.B. de C.V (LABB) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.020x

Based on the latest financial reports, Genomma Lab Internacional S.A.B. de C.V (LABB) has a cash flow conversion efficiency ratio of -0.020x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (MX$-229.17 Million ≈ $-13.19 Million USD) by net assets (MX$11.72 Billion ≈ $674.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Genomma Lab Internacional S.A.B. de C.V for the company's overall valuation and market capitalisation.

Genomma Lab Internacional S.A.B. de C.V - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Genomma Lab Internacional S.A.B. de C.V's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Genomma Lab Internacional S.A.B. de C.V Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Genomma Lab Internacional S.A.B. de C.V ranked by their cash flow conversion efficiency. Explore Genomma Lab Internacional S.A.B. de C.V cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Postal Realty Trust Inc
NYSE:PSTL
0.060x
Taihe Technologies
SHE:300801
0.033x
Prashkovsky
TA:PRSK
0.061x
Logistea AB Series B
ST:LOGI-B
0.017x
Shenzhen Pacific Union Precision Manufacturing Co. Ltd. A
SHG:688210
N/A
Thai Vegetable Oil Public Company Limited
BK:TVO-R
0.032x
Shanghai Smith Adhesive New
SHG:603683
0.023x
Enhabit Inc.
NYSE:EHAB
0.060x

Annual Cash Flow Conversion Efficiency for Genomma Lab Internacional S.A.B. de C.V (2005–2025)

The table below shows the annual cash flow conversion efficiency of Genomma Lab Internacional S.A.B. de C.V from 2005 to 2025. View LABB share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 MX$11.11 Billion
≈ $639.47 Million
MX$2.05 Billion
≈ $118.24 Million
0.185x -29.37%
2024-12-31 MX$11.59 Billion
≈ $666.93 Million
MX$3.03 Billion
≈ $174.59 Million
0.262x +39.15%
2023-12-31 MX$9.38 Billion
≈ $539.98 Million
MX$1.77 Billion
≈ $101.58 Million
0.188x -7.05%
2022-12-31 MX$10.15 Billion
≈ $584.28 Million
MX$2.05 Billion
≈ $118.25 Million
0.202x +38.83%
2021-12-31 MX$10.07 Billion
≈ $579.66 Million
MX$1.47 Billion
≈ $84.50 Million
0.146x -18.08%
2020-12-31 MX$9.63 Billion
≈ $554.45 Million
MX$1.71 Billion
≈ $98.67 Million
0.178x +40.93%
2019-12-31 MX$7.97 Billion
≈ $458.91 Million
MX$1.01 Billion
≈ $57.95 Million
0.126x -39.97%
2018-12-31 MX$7.43 Billion
≈ $427.47 Million
MX$1.56 Billion
≈ $89.92 Million
0.210x +6.49%
2017-12-31 MX$7.05 Billion
≈ $405.65 Million
MX$1.39 Billion
≈ $80.13 Million
0.198x -13.06%
2016-12-31 MX$6.79 Billion
≈ $390.93 Million
MX$1.54 Billion
≈ $88.83 Million
0.227x +76.83%
2015-12-31 MX$9.25 Billion
≈ $532.26 Million
MX$1.19 Billion
≈ $68.39 Million
0.128x +29.94%
2014-12-31 MX$10.50 Billion
≈ $604.46 Million
MX$1.04 Billion
≈ $59.77 Million
0.099x -53.30%
2013-12-31 MX$8.84 Billion
≈ $508.48 Million
MX$1.87 Billion
≈ $107.66 Million
0.212x +1222.65%
2011-12-31 MX$5.57 Billion
≈ $320.72 Million
MX$89.21 Million
≈ $5.13 Million
0.016x -92.25%
2010-12-31 MX$4.11 Billion
≈ $236.63 Million
MX$849.67 Million
≈ $48.90 Million
0.207x +63.53%
2009-12-31 MX$3.05 Billion
≈ $175.57 Million
MX$385.52 Million
≈ $22.19 Million
0.126x +27.65%
2008-12-31 MX$2.31 Billion
≈ $133.06 Million
MX$228.89 Million
≈ $13.17 Million
0.099x -43.72%
2007-12-31 MX$587.44 Million
≈ $33.81 Million
MX$103.33 Million
≈ $5.95 Million
0.176x +59.27%
2005-12-31 MX$164.93 Million
≈ $9.49 Million
MX$18.21 Million
≈ $1.05 Million
0.110x --

About Genomma Lab Internacional S.A.B. de C.V

MX:LABB Mexico Drug Manufacturers - Specialty & Generic
Market Cap
$707.31 Million
MX$12.29 Billion MXN
Market Cap Rank
#10651 Global
#93 in Mexico
Share Price
MX$12.57
Change (1 day)
+0.32%
52-Week Range
MX$12.29 - MX$19.37
All Time High
MX$28.88
About

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products t… Read more